Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
Apr. 17 | BTIG Adjusts Price Target on Cullinan Oncology to $30 From $20, Maintains Buy Rating | MT |
Apr. 16 | HC Wainwright Cuts Cullinan Oncology's Price Target to $29 From $34, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 4M | |
-5.74% | 4.11B | |
-10.88% | 3.34B | |
+2.65% | 1.55B | |
+33.83% | 1.25B | |
+82.85% | 881M | |
+32.63% | 917M | |
+12.36% | 558M | |
-24.60% | 561M | |
-.--% | 153M |
- Stock Market
- Equities
- CGEM Stock
- News Consolidated Gems, Inc.
- Cullinan Oncology Gets FDA Clearance for CLN-617 Study